We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current NXTC market cap is 40.46M. The company's latest EPS is USD -2.2479 and P/E is -0.68.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.24M | -17.77M | -17.07M | -19.16M | -15.62M |
| Net Income | -18.91M | -17.3M | -16.1M | -17.86M | -14.3M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.35M | 22.38M | 0 | 0 | 0 |
| Operating Income | -37.48M | -41.23M | -70.77M | -75.91M | -67.64M |
| Net Income | -33.74M | -36.6M | -69.39M | -74.73M | -62.72M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 189.91M | 184.16M | 167.79M | 153.38M | 139.94M |
| Total Liabilities | 8.37M | 16.63M | 13.59M | 14.95M | 13.49M |
| Total Equity | 181.54M | 167.53M | 154.2M | 138.43M | 126.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 356.17M | 306.64M | 242.39M | 184.16M | 128.04M |
| Total Liabilities | 34.68M | 12.92M | 9M | 16.63M | 13.62M |
| Total Equity | 321.48M | 293.72M | 233.39M | 167.53M | 114.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -44.94M | -53.89M | -14.78M | -29.53M | -42.3M |
| Investing | 63.51M | 67.98M | 18.12M | 24.83M | 35.11M |
| Financing | 139k | 200k | N/A | 83k | 83k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.62M | -44.95M | -57.24M | -53.89M | -52.97M |
| Investing | -303.92M | 43.52M | 36.6M | 67.98M | 39.27M |
| Financing | 243.04M | -1.42M | -3.27M | 200k | 154k |
| Market Cap | 40.46M |
| Price to Earnings Ratio | -0.68 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.26 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 27.9M |
| Average Volume (1 week) | 251.79k |
| Average Volume (1 Month) | 154.79k |
| 52 Week Change | -7.05% |
| 52 Week High | 2.57 |
| 52 Week Low | 0.98 |
| Spread (Intraday) | 0.05 (3.45%) |
| Company Name | NextCure Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.nextcure.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
